GLP-1 receptor agonists are a class of medications that mimic glucagon-like peptide-1, a gut hormone the body normally releases in response to food
Alessio N, Stellavato A, Squillaro T, et al
Important safety considerations include: Cardiovascular history : Patients with established cardiovascular disease require careful assessment, though recent evidence suggests GLP-1 receptor agonists may offer cardiovascular benefits Medication interactions : No clinically significant interactions are expected between GLP-1 receptor agonists and statins or other lipid-lowering medications, though delayed gastric emptying could theoretically affect absorption of oral medications Pancreatitis risk : Whilst rare, acute pancreatitis has been reported with GLP-1 receptor agonists
Coupled with endogenous reactive oxygen species (ROS) generated as by-products of various cellular processes, strict regulation of antioxidants is critical to maintaining a balanced reduction/oxidation (redox) state
A must-have for a luminous, youthful-looking complexion